Globus Medical, Inc. Provides Preliminary Unaudited Sales Guidance for the Fourth Quarter and Full Year Ended December 31, 2017 and Provides Earnings Guidance for the Full Year of Fiscal 2018
January 09, 2018 at 01:30 pm
Share
Globus Medical, Inc. provided preliminary unaudited sales guidance for the fourth quarter and full year ended December 31, 2017 and earnings guidance for the full year of fiscal 2018. The company anticipates fourth quarter 2017 sales of approximately $175.5 million, an increase of 15.8% over the fourth quarter 2016.
Full year 2017 estimated sales are expected to be approximately $635.4 million, an increase of 12.7% over the prior year.
The company established full year 2018 guidance of $690 million in sales and fully diluted non-GAAP earnings per share of $1.50. This EPS guidance assumes a full year benefit of tax reform, renewed suspension of the medical device tax and increased investment in Emerging Technologies.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Globus Medical, Inc. Provides Preliminary Unaudited Sales Guidance for the Fourth Quarter and Full Year Ended December 31, 2017 and Provides Earnings Guidance for the Full Year of Fiscal 2018
GLOBUS MEDICAL, INC. 
